The present study successfully developed orally deliverable multimodular
zinc (Zn)
iron oxide (Fe3O4)-saturated bovine
lactoferrin (bLf)-loaded polymeric
nanocapsules (NCs), and evaluated their
theranostic potential (antitumor efficacy, magnetophotothermal efficacy and imaging capability) in an in vivo human xenograft CpG-island methylator phenotype (CIMP)-1(+)/CIMP2(-)/
chromosome instability-positive colonic
adenocarcinoma (Caco2) and
claudin-low, triple-negative (ER(-)/PR(-)/HER2(-); MDA-MB-231)
breast cancer model. Mice fed orally on the Zn-Fe-bLf NC diet showed downregulation in
tumor volume and complete regression in
tumor volume after 45 days of feeding. In human xenograft
colon cancer, vehicle-control NC diet-group (n=5) mice showed a
tumor volume of 52.28±11.55 mm(3), and Zn-Fe-bLf NC diet (n=5)-treated mice had a
tumor-volume of 0.10±0.073 mm(3). In the human xenograft
breast cancer model, Zn-Fe-bLf NC diet (n=5)-treated mice showed a
tumor volume of 0.051±0.062 mm(3) within 40 days of feeding. Live mouse imaging conducted by near-infrared fluorescence imaging of Zn-Fe-bLf NCs showed
tumor site-specific localization and regression of colon and
breast tumor volume. Ex vivo fluorescence-imaging analysis of the vital organs of mice exhibited sparse localization patterns of Zn-Fe-bLf NCs and also confirmed
tumor-specific selective localization patterns of Zn-Fe-bLf NCs. Dual imaging using magnetic resonance imaging and computerized tomography scans revealed an unprecedented
theranostic ability of the Zn-Fe-bLf NCs. These observations warrant consideration of multimodular Zn-Fe-bLf NCs for real-time
cancer imaging and simultaneous
cancer-targeted
therapy.